Financhill
Back

Enovis 10K Form

Sell
38

ENOV
Enovis

Last Price:
55.09
Seasonality Move:
1.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ENOV News And Ratings

See the #1 stock for the next 7 days that we like better than ENOV

ENOV Financial Statistics

Sales & Book Value

Annual Sales: $1.71B
Cash Flow: $40.47M
Price / Cash Flow: 239.79
Annual Sales: $62.61
Price / Book: 0.9

Profitability

EPS (TTM): -0.61000
Net Income (TTM): $-33.26M
Gross Margin: $990.78M
Return on Equity: -0.97%
Return on Assets: -0.76%

Enovis Earnings Forecast

Key Enovis Financial Ratios

  • The Gross Profit Margin over the past 20 years for ENOV is 58.04%.
  • The Selling, General & Administrative Expenses for ENOV have been equal to 48.64% of Gross Profit Margin.
  • The Research & Development expenses have been 4.41% of Revenue.
  • The Interest Expense is -59.38% of Operating Income.
  • The Net Earning history of ENOV is -1.95% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 9 years.

Enovis Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ENOV
Website: enovis.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 2.43
Quick Ratio: 0.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 18.44

ENOV Technical Analysis vs Fundamental Analysis

Sell
38
Enovis (ENOV) is a Sell

Is Enovis a Buy or a Sell?

  • Enovis stock is rated a Sell
    The current Enovis [ENOV] share price is $56.17. The Score for ENOV is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.